Judging the Abortion Pill
By Editor - Thu Mar 16, 2:35 pm
- Comments Off on Judging the Abortion Pill
- Tweet
The Host Julie Rovner KHN @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KHN’s weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to Z,” now in its third edition. This week, the eyes of the nation are on Texas, where a federal judge who formerly worked for a conservative Christian advocacy group is set to decide whether the abortion pill mifepristone can stay on the market. Mifepristone is half of a two-pill regimen that now accounts for more than half of the abortions in the United States. Meanwhile, Novo Nordisk, another of the three large drug companies that dominate the market for diabetes treatments, has announced it will cut the price of many of its insulin products
Read more:
- Comments Off on Judging the Abortion Pill
- Tweet